Ali E. Yesilkanal

1.1k total citations
10 papers, 733 citations indexed

About

Ali E. Yesilkanal is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Ali E. Yesilkanal has authored 10 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Ali E. Yesilkanal's work include Melanoma and MAPK Pathways (4 papers), Cancer Mechanisms and Therapy (3 papers) and Epigenetics and DNA Methylation (3 papers). Ali E. Yesilkanal is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Cancer Mechanisms and Therapy (3 papers) and Epigenetics and DNA Methylation (3 papers). Ali E. Yesilkanal collaborates with scholars based in United States, Brazil and Switzerland. Ali E. Yesilkanal's co-authors include Marsha Rich Rosner, Dorothy A. Sipkins, Elizabeth Hyjek, Trevor Price, Benjamin Boyerinas, Christopher J. Mariani, Lucy A. Godley, Jozef Madžo, Payal Tiwari and Casey Frankenberger and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Ali E. Yesilkanal

9 papers receiving 732 citations

Peers

Countries citing papers authored by Ali E. Yesilkanal

Since Specialization

Citations

This map shows the geographic impact of Ali E. Yesilkanal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali E. Yesilkanal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali E. Yesilkanal more than expected).

Fields of papers citing papers by Ali E. Yesilkanal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali E. Yesilkanal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali E. Yesilkanal. The network helps show where Ali E. Yesilkanal may publish in the future.

Co-authorship network of co-authors of Ali E. Yesilkanal

This figure shows the co-authorship network connecting the top 25 collaborators of Ali E. Yesilkanal. A scholar is included among the top collaborators of Ali E. Yesilkanal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali E. Yesilkanal. Ali E. Yesilkanal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	HYENA detects oncogenes activated by distal enhancers in cancer 2024 ·Nucleic Acids Research ·(unknown), Ali E. Yesilkanal, (unknown), Fan Wang, Yang Yang, William D. Phillips, Xiaoyang Wu, Alexander Muir, Xin He, François Spitz, Lixing Yang	1
2	New strategies for targeting kinase networks in cancer 2021 ·Journal of Biological Chemistry ·Ali E. Yesilkanal, Gary L. Johnson, Alexandre F. Ramos, Marsha Rich Rosner	28
3	Limited inhibition of multiple nodes in a driver network blocks metastasis 2021 ·eLife ·Ali E. Yesilkanal, Dongbo Yang, (unknown), Payal Tiwari, (unknown), Long C. Nguyen, Jiyoung Lee, Amy Xie, Siqi Sun, (unknown), (unknown), (unknown), Timothy J. Stuhlmiller, Casey Frankenberger, Elizabeth J. Goldsmith, Gary L. Johnson, Alexandre F. Ramos, Marsha Rich Rosner	19
4	Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism 2019 ·Nature ·Ji‐Young Lee, Ali E. Yesilkanal, Joseph Wynne, Casey Frankenberger, Juan Liu, Jielin Yan, Mohamad Elbaz, Daniel C. Rabe, Felicia Rustandy, Payal Tiwari, (unknown), Peter C. Hart, Christie Kang, Sydney M. Sanderson, Jorge Andrade, Daniel K. Nomura, Marcelo G. Bonini, Jason W. Locasale, Marsha Rich Rosner	260
5	Targeting Raf Kinase Inhibitory Protein Regulation and Function 2018 ·Cancers ·Ali E. Yesilkanal, Marsha Rich Rosner	30
6	Abstract 3251: Regulation of TNBC kinome by the metastasis suppressor Raf kinase inhibitory protein (RKIP) 2015 ·Cancer Research ·Ali E. Yesilkanal, Casey Frankenberger, Daniel C. Rabe, Gary L. Johnson, Marsha Rich Rosner	0
7	TET1-Mediated Hydroxymethylation Facilitates Hypoxic Gene Induction in Neuroblastoma 2014 ·Cell Reports ·Christopher J. Mariani, Aparna Vasanthakumar, Jozef Madžo, Ali E. Yesilkanal, Tushar D. Bhagat, Yiting Yu, Sanchari Bhattacharyya, Roland H. Wenger, Susan L. Cohn, Jayasri Nanduri, Amit Verma, Nanduri R. Prabhakar, Lucy A. Godley	135
8	Raf Kinase Inhibitory Protein (RKIP) as a Metastasis Suppressor: Regulation of Signaling Networks in Cancer 2014 ·Critical Reviews™ in Oncogenesis ·Ali E. Yesilkanal, Marsha Rich Rosner	45
9	Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy 2013 ·Blood ·Benjamin Boyerinas, (unknown), Ali E. Yesilkanal, Trevor Price, Elizabeth Hyjek, Dorothy A. Sipkins	179
10	Alterations of 5-Hydroxymethylcytosine in Human Cancers 2013 ·Cancers ·Christopher J. Mariani, Jozef Madžo, Erika L. Moen, Ali E. Yesilkanal, Lucy A. Godley	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact